CERo Therapeutics (NASDAQ:CERO) Trading 4.6% Higher – Here’s What Happened

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares were up 4.6% on Monday . The company traded as high as $1.03 and last traded at $0.95. Approximately 435,535 shares traded hands during mid-day trading, an increase of 17% from the average daily volume of 373,681 shares. The stock had previously closed at $0.91.

CERo Therapeutics Trading Up 4.6 %

The firm has a fifty day moving average of $1.75 and a 200-day moving average of $7.48.

Institutional Trading of CERo Therapeutics

A hedge fund recently raised its stake in CERo Therapeutics stock. ARCH Venture Management LLC lifted its position in shares of CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) by 550.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 9,393,561 shares of the company’s stock after purchasing an additional 7,949,265 shares during the quarter. CERo Therapeutics comprises approximately 0.2% of ARCH Venture Management LLC’s holdings, making the stock its 9th largest holding. ARCH Venture Management LLC owned approximately 626.24% of CERo Therapeutics worth $564,000 at the end of the most recent quarter. 29.64% of the stock is owned by hedge funds and other institutional investors.

About CERo Therapeutics

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.